Orthocell Ltd (ASX:OCC) MD Paul Anderson tells Proactive the company has appointed Dr Ravi I Thadhani MD, MPH, an experienced US-based healthcare executive, as an independent non-executive director. Dr Thadhani has more than 30 years of specialist experience in the US healthcare sector and is a well-regarded executive, medical administrator and researcher.

#ProactiveInvestors #Orthocell #asx #biotech

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews